APO RESEARCH · REPORT
Cell Therapy
Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
Product & engineering
Understand the product.
Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
Selected research
Industry Growth & Trends
Global Cell Therapy Industry Growth and Trends Forecast to 2032
Market perspective
Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
According to APO Research, the global Cell Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Cell Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Cell Therapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cell Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cell Therapy.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Cell Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Cell Therapy Market by Company
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Cell Therapy Segment by Type
Stem Cell
Non-Stem Cell
Cell Therapy Segment by Application
Hospital
Clinic
Cell Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Cell Therapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Stem Cell
- Non-Stem Cell
Applications
- Hospital
- Clinic
Companies covered
- Gilead Sciences
- Novartis
- Osiris
- Vericel Corporation
- Vcanbio
- Fujifilm Cellular Dynamics
- JCR Pharmaceuticals
- Beike Biotechnology
- Golden Meditech
- Guanhao Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Cell Therapy Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Cell Therapy Market Size by Region (2021-2032)
- 1.4.1 Global Cell Therapy Market Size by Region (2021-2026)
- 1.4.2 Global Cell Therapy Market Size by Region (2027-2032)
- 1.5 Key Regions Cell Therapy Market Size (2021-2032)
- 1.5.1 North America Cell Therapy Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Cell Therapy Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Cell Therapy Market Size Growth Rate (2021-2032)
- 1.5.4 South America Cell Therapy Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Cell Therapy Market Size Growth Rate (2021-2032)
2 Cell Therapy Market by Type
- 2.1 Type Introduction
- 2.1.1 Stem Cell
- 2.1.2 Non-Stem Cell
- 2.2 Global Cell Therapy Market Size by Type
- 2.2.1 Global Cell Therapy Market Size Overview by Type (2021-2032)
- 2.2.2 Global Cell Therapy Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Cell Therapy Market Size Forecasted by Type (2027-2032)
- 2.3 Global Cell Therapy Market Size by Regions
- 2.3.1 North America Cell Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Cell Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Cell Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Cell Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Cell Therapy Market Size Breakdown by Type (2021-2026)
3 Cell Therapy Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.2 Global Cell Therapy Market Size by Application
- 3.2.1 Global Cell Therapy Market Size Overview by Application (2021-2032)
- 3.2.2 Global Cell Therapy Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Cell Therapy Market Size Forecasted by Application (2027-2032)
- 3.3 Global Cell Therapy Market Size by Regions
- 3.3.1 North America Cell Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Cell Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Cell Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Cell Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Cell Therapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Cell Therapy Industry Trends
- 4.2 Cell Therapy Industry Drivers
- 4.3 Cell Therapy Industry Opportunities and Challenges
- 4.4 Cell Therapy Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Cell Therapy Revenue (2021-2026)
- 5.2 Global Cell Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Cell Therapy Key Company Headquarters & Area Served
- 5.4 Global Cell Therapy Company, Product Type & Application
- 5.5 Global Cell Therapy Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Cell Therapy Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Cell Therapy Players Market Share by Revenue in 2025
- 5.6.3 2025 Cell Therapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Gilead Sciences
- 6.1.1 Gilead Sciences Company Information
- 6.1.2 Gilead Sciences Business Overview
- 6.1.3 Gilead Sciences Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Gilead Sciences Cell Therapy Product Portfolio
- 6.1.5 Gilead Sciences Recent Developments
- 6.2 Novartis
- 6.2.1 Novartis Company Information
- 6.2.2 Novartis Business Overview
- 6.2.3 Novartis Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Novartis Cell Therapy Product Portfolio
- 6.2.5 Novartis Recent Developments
- 6.3 Osiris
- 6.3.1 Osiris Company Information
- 6.3.2 Osiris Business Overview
- 6.3.3 Osiris Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Osiris Cell Therapy Product Portfolio
- 6.3.5 Osiris Recent Developments
- 6.4 Vericel Corporation
- 6.4.1 Vericel Corporation Company Information
- 6.4.2 Vericel Corporation Business Overview
- 6.4.3 Vericel Corporation Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Vericel Corporation Cell Therapy Product Portfolio
- 6.4.5 Vericel Corporation Recent Developments
- 6.5 Vcanbio
- 6.5.1 Vcanbio Company Information
- 6.5.2 Vcanbio Business Overview
- 6.5.3 Vcanbio Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Vcanbio Cell Therapy Product Portfolio
- 6.5.5 Vcanbio Recent Developments
- 6.6 Fujifilm Cellular Dynamics
- 6.6.1 Fujifilm Cellular Dynamics Company Information
- 6.6.2 Fujifilm Cellular Dynamics Business Overview
- 6.6.3 Fujifilm Cellular Dynamics Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Fujifilm Cellular Dynamics Cell Therapy Product Portfolio
- 6.6.5 Fujifilm Cellular Dynamics Recent Developments
- 6.7 JCR Pharmaceuticals
- 6.7.1 JCR Pharmaceuticals Company Information
- 6.7.2 JCR Pharmaceuticals Business Overview
- 6.7.3 JCR Pharmaceuticals Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 JCR Pharmaceuticals Cell Therapy Product Portfolio
- 6.7.5 JCR Pharmaceuticals Recent Developments
- 6.8 Beike Biotechnology
- 6.8.1 Beike Biotechnology Company Information
- 6.8.2 Beike Biotechnology Business Overview
- 6.8.3 Beike Biotechnology Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Beike Biotechnology Cell Therapy Product Portfolio
- 6.8.5 Beike Biotechnology Recent Developments
- 6.9 Golden Meditech
- 6.9.1 Golden Meditech Company Information
- 6.9.2 Golden Meditech Business Overview
- 6.9.3 Golden Meditech Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Golden Meditech Cell Therapy Product Portfolio
- 6.9.5 Golden Meditech Recent Developments
- 6.10 Guanhao Biotech
- 6.10.1 Guanhao Biotech Company Information
- 6.10.2 Guanhao Biotech Business Overview
- 6.10.3 Guanhao Biotech Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Guanhao Biotech Cell Therapy Product Portfolio
- 6.10.5 Guanhao Biotech Recent Developments
7 North America
- 7.1 North America Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Cell Therapy Market Size by Country (2021-2026)
- 7.3 North America Cell Therapy Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Cell Therapy Market Size by Country (2021-2026)
- 8.3 Europe Cell Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Cell Therapy Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Cell Therapy Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Cell Therapy Market Size by Country (2021-2026)
- 10.3 South America Cell Therapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Cell Therapy Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Cell Therapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst